PD-L1 Enhances c-MET Resistance to Osimertinib in NSCLC
In an exciting new study, researchers have unveiled critical insights into the mechanisms that underpin resistance to osimertinib, a targeted ...
In an exciting new study, researchers have unveiled critical insights into the mechanisms that underpin resistance to osimertinib, a targeted ...
PHILADELPHIA, PA – In a striking advancement for personalized cancer treatment, the NRG Oncology-led NRG-GU009 (PREDICT-RT) trial, which explores the ...
In a groundbreaking advancement for personalized cancer care, researchers at the Moffitt Cancer Center have developed innovative machine learning models ...
Bar-Ilan University has recently become a central figure in an ambitious new European initiative that aims to dramatically transform the ...
In recent years, the realm of cancer immunotherapy has witnessed revolutionary strides, particularly through the development and clinical success of ...
In a groundbreaking advancement at the intersection of oncology and artificial intelligence, researchers from Southern Medical University in China have ...
In a groundbreaking advance in the field of oncology, a multidisciplinary research collaboration has unveiled a pioneering gastric cancer model ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine